Evidence map›Paper›PMID 24612976›Full record

Trial reportOphthalmology2014

Visual recovery in treated bacterial keratitis.

Muthiah Srinivasan, Jeena Mascarenhas, Revathi Rajaraman, Meenakshi Ravindran, Prajna Lalitha, Kathryn J Ray, Michael E Zegans, Nisha R Acharya, Thomas M Lietman, Jeremy D Keenan and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Ophthalmology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Topical corticosteroids as adjunctive therapy for bacterial keratitis.The Cochrane database of systematic reviews · 2014
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Role of steroids in the treatment of bacterial keratitis.Clinical ophthalmology (Auckland, N.Z.) · 2016
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Muthiah SrinivasanDepartment of Cornea and External Diseases, Aravind Eye Care System, Madurai, India.
Jeena MascarenhasDepartment of Cornea and External Diseases, Aravind Eye Care System, Madurai, India.
Revathi RajaramanDepartment of Cornea and External Diseases, Aravind Eye Care System, Coimbatore, India.
Meenakshi RavindranDepartment of Pediatric Ophthalmology, Aravind Eye Care System, Tirunelveli, India.
Prajna LalithaDepartment of Ocular Microbiology, Aravind Eye Care System, Madurai, India.
Kathryn J RayFrancis I. Proctor Foundation, University of California, San Francisco.
Michael E ZegansDepartment of Surgery (Ophthalmology), Dartmouth Medical School, Lebanon, New Hampshire; Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, New Hampshire.
Nisha R AcharyaFrancis I. Proctor Foundation, University of California, San Francisco; Department of Ophthalmology, University of California, San Francisco.
Thomas M LietmanFrancis I. Proctor Foundation, University of California, San Francisco; Department of Ophthalmology, University of California, San Francisco; Department of Epidemiology & Biostatistics, University of California, San Francisco.
Jeremy D KeenanFrancis I. Proctor Foundation, University of California, San Francisco; Department of Ophthalmology, University of California, San Francisco.
Steroids for Corneal Ulcers Trial Group

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAMBA, DEEPAK ASHOK · 1985 to 2024
$16.8M
The Steroids for Cornea Ulcers TrialU10EY015114 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M · 2005 to 2009
$2.4M
Predicting and Improving Clinical Outcomes for Bacterial KeratitisK23EY017897 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ACHARYA, NISHA · 2007 to 2011
$1.1M
Optimal trachoma control after mass antibiotic distributionsK23EY019071 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KEENAN, JEREMY DAVID · 2008 to 2012
$982k
NEI NIH HHS EY02162NEI NIH HHS K23 EY017897NEI NIH HHS K23 EY019071NEI NIH HHS P30 EY002162NEI NIH HHS U10 EY015114
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAnti-Bacterial AgentsAza CompoundsCorneal UlcerEye Infections, BacterialFemaleFluoroquinolonesGlucocorticoidsHumansMaleMiddle AgedMoxifloxacinPrednisoloneQuinolinesRecovery of FunctionAnti-Bacterial AgentsAza CompoundsFluoroquinolonesGlucocorticoidsMoxifloxacinPrednisoloneprednisolone phosphateQuinolines

Identifiers

PMID24612976
PMCPMC4047131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.